• USA Home
  • P3115 - Protein Kinase C Inhibitor, Myristoylated

EMAIL THIS PAGE TO A FRIEND
P3115 Sigma

Protein Kinase C Inhibitor, Myristoylated

≥7.5 mg/mL (peptide and counter ion), ≥95% (Minimum peptide content 70%, HPLC), aqueous solution (neutral pH)

Synonym: Myr-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val, Myr-RFARKGALRQKNV

Purchase

Properties

Related Categories Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience,
assay   ≥95% (Minimum peptide content 70%, HPLC)
form   aqueous solution (neutral pH)
mol wt   mol wt 1,754.3 Da (Fast Atomic Bombardment Mass Spectrometry)
  mol wt 1.75 kDa
composition   Peptide content, ≥70%
concentration   ≥7.5 mg/mL (peptide and counter ion)
shipped in   dry ice
storage temp.   −20°C

Description

Application

Protein Kinase C (PKC) Inhibitor, Myristoylated is supplied ready for use in kinase reactions. An inhibitor peptide (concentration of 50 to 100 μM) is recommended, depending on the concentration of PKC and the duration of the incubation.

Biochem/physiol Actions

Protein Kinase C Inhibitor, Myristoylated is a cell permeable, specific inhibitor of calcium and phospholipid-dependent Protein Kinase C.

Price and Availability


Better Together

Discover your Target

Biomedical Applications
Safety & Documentation

Safety Information

RIDADR 
NONH for all modes of transport
WGK Germany 
3

Documents

Certificate of Analysis

Certificate of Origin

Protocols & Articles
Peer-Reviewed Papers
15

References

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?